<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2025 (11) TMI 1666 - ITAT AHMEDABAD</title>
    <link>https://www.taxtmi.com/caselaws?id=782198</link>
    <description>ITAT Ahmedabad partly allowed the assessee&#039;s appeal. On the issue of pro-rata allocation of expenses post slump sale (25.03.2017 to 31.03.2017), the matter was remanded to the AO to verify from the books of both entities whether any such expenditure was actually claimed and to decide afresh in accordance with law. The disallowance of employees&#039; contribution to Provident Fund was deleted, holding that payment made on the next working day when the due date fell on a Sunday is deemed timely. Disallowances relating to software expenditure and consultancy fees (including for US FDA approval) were also deleted, both being held revenue in nature allowable under section 37(1).</description>
    <language>en-us</language>
    <pubDate>Wed, 29 Oct 2025 00:00:00 +0530</pubDate>
    <lastBuildDate>Wed, 26 Nov 2025 14:11:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=867216" rel="self" type="application/rss+xml"/>
    <item>
      <title>2025 (11) TMI 1666 - ITAT AHMEDABAD</title>
      <link>https://www.taxtmi.com/caselaws?id=782198</link>
      <description>ITAT Ahmedabad partly allowed the assessee&#039;s appeal. On the issue of pro-rata allocation of expenses post slump sale (25.03.2017 to 31.03.2017), the matter was remanded to the AO to verify from the books of both entities whether any such expenditure was actually claimed and to decide afresh in accordance with law. The disallowance of employees&#039; contribution to Provident Fund was deleted, holding that payment made on the next working day when the due date fell on a Sunday is deemed timely. Disallowances relating to software expenditure and consultancy fees (including for US FDA approval) were also deleted, both being held revenue in nature allowable under section 37(1).</description>
      <category>Case-Laws</category>
      <law>Income Tax</law>
      <pubDate>Wed, 29 Oct 2025 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=782198</guid>
    </item>
  </channel>
</rss>